|
|
Article: Cardiac Dimensions(R) Inc. Announces Completion of European AMAEDUS(TM) Study.
- Article from:
- Business Wire
- Article date:
- May 8, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Six Month Follow Up Completed for Investigation of the CARILLON[TM] Mitral Contour System[TM], a Percutaneous Approach for the Management of Functional Mitral Regurgitation (FMR)
KIRKLAND, Wash. -- Cardiac Dimensions[R], Inc. today announced it has completed its European AMADEUS[TM] study. AMADEUS[TM] (CARILLON[TM] Mitral Annuloplasty Device European Union Study) was a 30 patient safety and performance study of the CARILLON[TM] Mitral Contour System[TM] conducted at 6 centers in Germany, Poland, and the Netherlands. The study met its primary safety endpoint at 6 months, along with its secondary performance endpoints at 6 months. The complete results will be ...